The Center for Regenerative Medicine Joins the 51st Miami Winter Symposium

MIAMI, January 31, 2018 (Newswire.com) - ​​The Center for Regenerative Medicine joins the 51st Miami Winter Symposium. This year's symposium is centered on stem cells, where innovations and non-surgical techniques are unveiled for patients worldwide. Dr. Farshchian will be at the symposium to present innovative live cell treatment for Alzheimer’s.

Program highlights will include an international line-up of 25 renowned speakers – selected to provide delegates with a unique opportunity to meet with and hear from representatives from the leading research centers on all aspects of stem cell research.

The results authenticate the effectiveness of the administration of the intranasal live cells in an individual diagnosed with Alzheimer's disease.

Marie Barba, Director of Public Relations

Focused sessions on hot topics in stem cell research include stem cell reprogramming and differentiation, hematopoietic stem cells, stem cells in cancer, stem cells in vision, stem cell engineering and stem cells as a therapeutic resource, including clinical trials. The latest international research consisted of 12 spotlight talks and poster sessions featuring the latest research findings from around the world, including Dr. Farshchian, who has been working with regenerative medicine for over 20 years.

Dr. Farshchian presented a case of an 83-year-old patient with Alzheimer’s who responded to an intranasal treatment of live cell therapy. “The results authenticate the effectiveness of the administration of the intranasal live cells in an individual diagnosed with Alzheimer’s disease,” explained Vidya Maharajh, MPH, CRA, CSSGB, a CDC research expert and co-writing a study with of Dr. Farshchian.

As part of the objective measurement of the effectiveness of the therapy, Farshchian used the standard mini-mental status exam. As part of the exam, the patient is asked to draw a clock. Farshchian explained how the patient was able to go from a disorganized thought to a more concise clear ability to remember the clock concept at hand. According to Mr. Roman Garcia, PT and Dr. Farshchian's assistant; “maintaining objectivity in the pre- and post-examination protocol is vital for outcome evaluation.”

“Of the estimated 5.5 million Americans living with Alzheimer’s dementia in 2017, an estimated 5.3 million are age 65 and older and approximately 200,000 individuals are under age 65 and have younger-onset Alzheimer’s. One in 10 people age 65 and older (10 percent) has Alzheimer’s dementia,” according to Alzheimer's.org.

Dr. Farshchian, the medical director for The Center for Regenerative Medicine, which he founded in 2000 in order to pursue a pioneering regimen in the treatment of Arthritis and neurodegenerative diseases, is also a medical doctor, medical author and humanitarian in Miami Florida. In 2005 he performed the first autologous live cell transplantation into a knee in the U.S.A. Dr. Farshchian said, “I am very encouraged by the intranasal Live cell technique to treat Alzheimer’s, it is promising.” (http://www.arthritisusa.net/Optic-Regeneration)

Earlier today, the spokesman for Dr. Farshchian, Mr. Bernardo Lessa-Bastos said, “We are very proud to be contributing to our medical community by attending and sharing our experiences and extensive knowledge of Live stem cells at the 51st Miami Winter Symposium for Stem Cells.”

For further information, please contact The Center for Regenerative Medicine Representatives:

Bernard Lessa-Bastos
305-891-4686

Source: The Center for Regenerative Medicine